From theheart.org on Medscape

Medscape Medical News from the

Congress of the European Association of Percutaneous Cardiovascular Interventions (EuroPCR) 2014

May 20 - 23, 2014; Paris, France

This coverage is not sanctioned by, nor a part of, the European Society of Cardiology.

Conference News

EuroPCR Has FFR the Answers? Yes, Says POST-IT; Another Says Pause
Heartwire from Medscape, May 28, 2014
EuroPCR Metal-Free TAVR System Shows Success as FDA Approves Trial
Heartwire from Medscape, May 27, 2014
EuroPCR It Ain't Over: Renal Denervation Data Dominate EuroPCR
Heartwire from Medscape, May 26, 2014
EuroPCR Survival After TAVI: Longest Follow-up Yields Some Surprises
Heartwire from Medscape, May 23, 2014
EuroPCR EUROMAX Data Put Heat on HEAT via New Bivalirudin Analysis
Heartwire from Medscape, May 22, 2014

EuroPCR Sneak Peek at Draft Myocardial Revascularization Guidance
Heartwire from Medscape, May 21, 2014
EuroPCR Morphine May Delay Onset of New Antiplatelets in Primary PCI
Heartwire from Medscape, May 21, 2014
EuroPCR SAPIEN3: Next-Gen Transcatheter Valve Cuts Deaths, Strokes
Heartwire from Medscape, May 20, 2014
EuroPCR STEMI in Women: Same Plaques, Same Stent Outcomes: OCTAVIA
Heartwire from Medscape, May 20, 2014

Perspectives

ACS Antithrombotics: Back to the Future?
Gilles Montalescot, MD, PhD
Choices, Choices: PCI Adjunctive Pharmacotherapy
Thomas Cuisset, MD, PhD; Roxana Mehran, MD
Renal Denervation: A Deeper Dive
David E. Kandzari, MD; Stephen G. Worthley, MB BS, PhD
TAVR Antithrombotic Therapy: An Evidence-Free Zone
A. Pieter Kappetein, MD, PhD; Gilles Montalescot, MD, PhD
You Say TAVR, I Say TAVI: The Latest From Europe
A. Pieter Kappetein, MD, PhD

Previous Coverage